Philips has recently unveiled its new cardiograph featuring 16 leads and the company’s proprietary DXL signal analysis algorithm.
From the press release:
Confirming Philips’ commitment to develop technologies and solutions for women’s health, the DXL Algorithm applies new gender, age and lead-specific STEMI (ST-segment Elevation Myocardial Infarction) criteria to detect acute MI in women as well as men. A widespread pattern of ST depression often reflects global ischemia due to left main coronary obstruction, multi-vessel obstructions, or microvascular disease, which is more prevalent in women. The DXL Algorithm incorporates new criteria for these conditions and provides a Critical Value of "Global Ischemia" to highlight that prompt intervention may be needed. The new algorithm also builds upon Philips’ long use of gender and age-specific criteria left ventricular hypertrophy and prolonged QT interval.
Unveiled at this year’s AHA, the PageWriter TC70 cardiograph not only incorporates the new DXL Algorithm, but also improves workflow and enables faster clinical decision making. ECG reports are quickly taken and transferred to the TraceMasterVue ECG management system with the click of a single button. Bedside decision making is enhanced with the automatic retrieval of the previous ECG, allowing for immediate clinical serial comparison.
The new PageWriter TC70 includes technologies that are especially useful in the Emergency Department, where ECG reports can highlight test results that may warrant immediate clinical attention. When used with the DXL 16-Lead Algorithm, the PageWriter TC70 provides a powerful tool to reduce a hospital’s door-to-balloon times.
There is increasing interest within the Emergency Department to manage STEMI often seen in the early stages of a heart attack. Incorporating new criteria based on recent scientific discoveries, the Philips DXL Algorithm’s STEMI-CA criteria examine the lead distribution of ST elevation to determine the artery that is most likely to harbor an obstruction (the culprit artery). Patented ST Maps which show the spatial orientation of STEMI provide an easier perception of the ischemic areas. Using these data, clinicians can quickly decide on the next appropriate management steps for the patient.